SE431544B - ANALOGY PROCEDURE FOR PREPARATION OF PHARMACOLOGICALLY ACTIVE 4-PYRIMIDON DERIVATIVES - Google Patents

ANALOGY PROCEDURE FOR PREPARATION OF PHARMACOLOGICALLY ACTIVE 4-PYRIMIDON DERIVATIVES

Info

Publication number
SE431544B
SE431544B SE7614620A SE7614620A SE431544B SE 431544 B SE431544 B SE 431544B SE 7614620 A SE7614620 A SE 7614620A SE 7614620 A SE7614620 A SE 7614620A SE 431544 B SE431544 B SE 431544B
Authority
SE
Sweden
Prior art keywords
pyrimidon
derivatives
preparation
pharmacologically active
analogy procedure
Prior art date
Application number
SE7614620A
Other languages
Swedish (sv)
Other versions
SE7614620L (en
Inventor
T H Brown
G J Durant
C R Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of SE7614620L publication Critical patent/SE7614620L/en
Publication of SE431544B publication Critical patent/SE431544B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7614620A 1975-12-29 1976-12-28 ANALOGY PROCEDURE FOR PREPARATION OF PHARMACOLOGICALLY ACTIVE 4-PYRIMIDON DERIVATIVES SE431544B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5300175 1975-12-29

Publications (2)

Publication Number Publication Date
SE7614620L SE7614620L (en) 1977-06-30
SE431544B true SE431544B (en) 1984-02-13

Family

ID=10466233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7614620A SE431544B (en) 1975-12-29 1976-12-28 ANALOGY PROCEDURE FOR PREPARATION OF PHARMACOLOGICALLY ACTIVE 4-PYRIMIDON DERIVATIVES

Country Status (37)

Country Link
JP (1) JPS5283388A (en)
AR (1) AR222290A1 (en)
AT (1) AT360024B (en)
AU (1) AU508123B2 (en)
BE (1) BE849810A (en)
BG (1) BG29722A3 (en)
CA (1) CA1073458A (en)
CH (1) CH631981A5 (en)
CS (1) CS203995B2 (en)
DD (1) DD128588A5 (en)
DE (1) DE2658267A1 (en)
DK (1) DK587076A (en)
EG (1) EG12439A (en)
ES (1) ES454656A1 (en)
FI (1) FI62668C (en)
FR (1) FR2336935A1 (en)
GR (1) GR62441B (en)
HU (1) HU175171B (en)
IE (1) IE45082B1 (en)
IL (1) IL51040A (en)
IT (2) IT1124740B (en)
LU (1) LU76481A1 (en)
MW (1) MW5076A1 (en)
MX (1) MX5119E (en)
NL (1) NL7614538A (en)
NO (1) NO146396C (en)
NZ (1) NZ182759A (en)
OA (1) OA05526A (en)
PH (1) PH14723A (en)
PL (1) PL104376B1 (en)
PT (1) PT65949B (en)
RO (1) RO72475A (en)
SE (1) SE431544B (en)
SU (1) SU791235A3 (en)
YU (1) YU311676A (en)
ZA (1) ZA767198B (en)
ZM (1) ZM14376A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
IL56265A (en) * 1977-12-28 1982-08-31 Om Lab Sa Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
IN151188B (en) * 1978-02-13 1983-03-05 Smith Kline French Lab
IL57005A (en) * 1978-04-11 1983-11-30 Smith Kline French Lab Process for the preparation of 2-amino pyrimid-4-one derivatives and novel 2-nitroaminopyrimid-4-ones as intermediates therefor
ZA792607B (en) * 1978-05-30 1980-07-30 Smith Kline French Lab Nitro compounds
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
US4255428A (en) 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
JPS55133379A (en) * 1979-04-05 1980-10-17 Smith Kline French Lab Pyrimidone compound
EP0017680B1 (en) * 1979-04-11 1982-04-21 Smith Kline & French Laboratories Limited Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (en) * 1975-10-02 1979-08-25 Smith Kline French Lab

Also Published As

Publication number Publication date
CH631981A5 (en) 1982-09-15
DD128588A5 (en) 1977-11-30
LU76481A1 (en) 1977-06-15
MX5119E (en) 1983-03-24
PT65949B (en) 1978-06-15
NL7614538A (en) 1977-07-01
FI62668C (en) 1983-02-10
IT7919107A0 (en) 1979-01-05
ES454656A1 (en) 1977-11-16
DE2658267A1 (en) 1977-07-07
YU311676A (en) 1983-01-21
NO146396B (en) 1982-06-14
AU508123B2 (en) 1980-03-13
FI763664A (en) 1977-06-30
CS203995B2 (en) 1981-03-31
CA1073458A (en) 1980-03-11
JPS6129355B2 (en) 1986-07-05
FI62668B (en) 1982-10-29
PL104376B1 (en) 1979-08-31
BE849810A (en) 1977-06-23
FR2336935B1 (en) 1980-03-21
ZM14376A1 (en) 1977-08-22
ATA960876A (en) 1980-05-15
GR62441B (en) 1979-04-12
IT1124740B (en) 1986-05-14
AR222290A1 (en) 1981-05-15
JPS5283388A (en) 1977-07-12
BG29722A3 (en) 1981-01-15
AU2097676A (en) 1978-07-06
NO146396C (en) 1982-09-22
IE45082B1 (en) 1982-06-16
DK587076A (en) 1977-06-30
PT65949A (en) 1977-01-01
FR2336935A1 (en) 1977-07-29
IL51040A0 (en) 1977-02-28
HU175171B (en) 1980-05-28
NO764370L (en) 1977-06-30
PH14723A (en) 1981-11-13
NZ182759A (en) 1978-06-02
IE45082L (en) 1977-06-29
MW5076A1 (en) 1978-02-08
RO72475A (en) 1982-10-26
EG12439A (en) 1979-09-30
IL51040A (en) 1980-12-31
OA05526A (en) 1981-04-30
SE7614620L (en) 1977-06-30
SU791235A3 (en) 1980-12-23
ZA767198B (en) 1977-11-30
AT360024B (en) 1980-12-10

Similar Documents

Publication Publication Date Title
NO147450C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CHINAZOLONE DERIVATIVES
NO792829L (en) ANALOGY PROCEDURE FOR PREPARATION OF PHARMACOLOGICALLY ACTIVE TETRAZOLYLALCOXY CARBOSTYRIC DERIVATIVES
NO148813C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE CARBOSTYRIC DERIVATIVES
NO141411C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE ERYTHROMYCIN DERIVATIVES
SE431088B (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZYDRYLSULPHINYL DERIVATIVES
SE431544B (en) ANALOGY PROCEDURE FOR PREPARATION OF PHARMACOLOGICALLY ACTIVE 4-PYRIMIDON DERIVATIVES
NO145792C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE PYRIMIDON DERIVATIVES
NO151040C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 5-HALOGENPYRIMID-2-ONES
NO146095C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CHINAZOLINE DERIVATIVES
NO146865C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 16-DEHYDRO ANDROSTAND DERIVATIVES
NO145842C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE INDOLICINE DERIVATIVES
NO145791C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES
NO146359C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYPROHEPTADIN DERIVATIVES
NO142838C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ISOQINOLINE DERIVATIVES
NO146022C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZOFENO DERIVATIVES
NO149388C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE CARBOSTYRIL DERIVATIVES
NO148454C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDINE-DIONE DERIVATIVES
NO143744C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE BENZ (DE) ISOKINOLINE DERIVATIVES
NO142524C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE CYCLOHEXYLPHENYL DERIVATIVES
NO143903C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-FLUORPYRIMIDIN-4-ON DERIVATIVES
NO145950C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE HOMOPHALIMIDES
NO145238C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DIHYDROCARBOSTYRIL DERIVATIVES
NO145197C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE MORPHOLINE COMPOUNDS
NO146672C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CINNOLIN DERIVATIVES
NO144741C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIOPYRANO-PYRAZOLES

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7614620-8

Effective date: 19941128

Format of ref document f/p: F